THE EFFECTS OF GENISTEIN-RICH EDAMAME ON LDL, HS-CRP LEVEL, NEUTROPHIL-LYMPHOCYTE RATIO AND MONOCYTE-LYMPHOCYTE RATIO: STUDY ON RAT MODEL OF ATHEROSCLEROSIS: Experimental Study in Atherosclerosis Induced Male Rats
DOI:
https://doi.org/10.36408/mhjcm.v8i1.450Keywords:
Genistein rich-edamame, LDL, hsCRP, neutrophil-lymphocyte ratio, monocyte-lymphocyte ratioAbstract
ABSTRACT
Background: Atherosclerosis is related to hypercholesterolaemia and inflammation. Edamame is one of the soybeans with high levels of genistein which protects the formation of atherosclerosis.
Purpose: This research aimed to evaluate the effects of genistein-rich edamame on LDL, hs-CRP, Neutrophil-Lymphocyte Ratio (NLR) and Monocyte-Lymphocyte Ratio (MLR) on atherosclerosis-induced mice.
Method: This research is a true experimental study with posttest only-controlled group design. Thirty male rats were divided randomly into five groups: negative control group without any intervention, positive control group with atherosclerosis induction, first intervention group with edamame extract supplementation, second intervention group with genistein-rich edamame extract supplementation, and third intervention group treated with atorvastatin. After 28 days, serum LDL, hs-CRP, LDL and MLR were measured.
Results: There were significant differences (p<0.001) of hs-CRP values between the second intervention group compared to the negative control, positive control and first intervention group. Edamame extract lowered LDL cholesterol levels in the second intervention group compared to positive control, but the difference were not statistically significant. There were significant differences (p<0.05) of MLR values between the second intervention group and the negative control and also the first intervention group, and significant differences between the second intervention group and the negative control and also the first intervention group. There was no significant difference on NLR values between all groups.
Conclusion: The administration of genistein rich edamame may reduces the inflammation in the blood vessels better than edamame extract represented by lower hs-CRP and MLR values compared to the edamame extract.
Keywords: Genistein rich-edamame, LDL, hsCRP, neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio
Downloads
References
Winkel LC, Hoogendoorn A, Xing R, Wentzel JJ, Van der Heiden K. Animal models of surgically manipulated flow velocities to study shearstress-induced atherosclerosis. Cardiology J Pharmacol Jornal. 2015;241(1):100–110.
Fishbein MC, Fishbein GA. Arteriosclerosis: Facts and fancy. Cardiovasc Pathol. 2015; 24(6):335–42.
Ohira T, Iso H. Cardiovascular disease epidemiology in Asia. Circ J . 2013;77(7):1646–52.
Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol J. 2014; 11(5):276-89.
Kesumasari C. Model prediksi suspek penyakit jantung koroner pada individu dan masyarakat di Indonesia. Makassar: Universitas Hasanuddin Press. 2009. p.1-11.
MOH National Institut of Health Research and Development (INA). Sample Registration System; Jakarta. 2015. p1-5.
Kemenkes RI. Riset Kesehatan Dasar, RISKESDAS. Jakarta: Balitbang Kemenkes RI. 2013; Bab III: 90-93.
Yuan Y, Li P, Ye J. Lipid homeostasis and the formations of macrophage-derived foam cells in atherosclerosis. Protein Cell. 2012 Mar;3(3):173-81.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-95
Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec 19-26;420(6917):868-74
Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015 Nov;278(5):483-493
Yilmaz M, Tenekecioglu E, Arslan B, Bekler A, Ozluk OA, Karaagac K, et al. White blood cell subtypes and neutrophil-limphocyte ratio in prediction of coronary thrombus formation in Non-ST-segment elevated acute coronary syndrome. Clin Appl Thromb Hemost.2015; 21(5):446-52
Araldi E, Chamorro JA, Solingen C, Fernandez HC, Suarez Y. Therapeutic potential of modulating microRNAs in atherosclerotic vascular disease. Curr Vasc Pharmacol. 2015;13(3):291-304.
Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653–657.
Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg. 2010; 52: 632 –6.
Ganda A, Magnusson M, Yvan-Charvet L, Hedblad B, Engstrom G, et al. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation. 2013 Mar 5;127(9):988–96.
Gary T, Pichler M, Belaj K, Eller P, Hafner F, Gerger A, et al. Lymphocyte to monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract. 2014 Dec;68(12):1483–7
Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008; 264: 295–314.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Crigui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-5115.
Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006;12:178-180
Zazula AD, Neto PD, Gomes AM, Kruklis H, Barbieri GF, Forte RY. An assessment of neutrophils and lymphocytes ratio in patients suspected of acute coronary syndrome. Arq Bras Cardiol. 2008 Jan;90(1):31–6
Muhmmed Suliman MA, Bahnacy Juma AA, Ali Almadhani AA, Pathare AV, Alkindi SSA, Uwe Werner F. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res. 2010 Nov; 41(8):618–22
Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: Current view and future perspective on lipoprotein modification treatment. Neth Heart J. 2017 Apr;25(4):231–42.
Sudaryanto T. Konsumsi Kedelai Indonesia. Bogor: IPB-Press. 1996. p.238-260.
Myers BD, Ross J, Newton L, Luetscher J, Perlroth M, de Arriba G. Indian medicinal plants. Plants One J. 2013;9(1):2045–8.
Ramdath D, Padhi E, Sarfaraz S, Renwick S, Duncan A. Beyond the cholesterol-lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease. Nutrients. 2017;9(4):324
Sargowo D. Patogenesis aterosklerosis: Malang: UB Press; 2015; Bab X: 257-295.
Kapiotis S, Held I, Ehringer H, Hermann M, Seelos C, Gmeiner BMK. Genistein, the Dietary-Derived Angiogenesis Inhibitor, Prevents LDL Oxidation and Protects Endothelial Cells From Damage by Atherogenic LDL.
Taku Kyoko, Umegaki Keizo, Ishimi Yoshiko, Watanabe Shaw. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials. Ther Clin Risk Manag. 2008 Oct; 4(5): 1097–1103.
Jee-Youn Shim, Yoo-Jung Kim, Hye-Sung Lee. Effects of soybean isoflavone extract on the plasma lipid profiles and antioxidant enzyme activity in streptozotocin-induced diabetic rats. Nut Research Pract 2008, 2(4):218-226
Clarkson TB. Soy, soy phytoestrogens and cardiovascular disease. J Nutr. 2002 Mar;132(3):566S-569S.
Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007 Apr;85(4):1148-56.
Farsi S, Azarbayjani MA, Hoseini SA, Peeri M. The Effects of Endurance Training with Genistein on ICAM-1, VCAM-1, and CRP of Diabetic Rats. IJDO 2016, 8(3): 121-128
Kamath, D. Y., Xavier, D., Sigamani, A., & Pais, P. (2015). High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective. The Indian Journal of Medical Research, 142(3), 261-8.
Horne BD, Anderson JL, John JM, Weasver A, Bair TL, Jensen Kr. Which white blood cell subtypes predict increased cardiovascular risk. J Am Coll Cardiol. 2005;45:1638-43
Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2013;9(6):418-28
Lee CS, Kwon SJ, Na SY, Lim SP, Lee JH. Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits. J Korean Med Sci, 2004 Oct; 19(5):656:661.
Mayer FJ, Gruenberger D, Schillinger M, Mannhalter C, Minar E, Koppensteiner R, Arbesu I, Niessner A, Hoke M. dkk. Prognostic value of neutrophils in patients with asymptomatic carotid artery disease. Atherosclerosis, 2013;231(2):274-280.
Allahverdian S, Pannu PS, Francis GA. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res. 2013;95:165–72
Gottstein N, Ewins BA, Eccleston C, Hubbard GP, Kavanagh IC, Minihane AM, Weinberg PD, Rimbach G. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr. 2003 May;89(5):607-16.
Urra X, Villamor N, Amaro S, Gomez-Choco M, Obach V, Oleaga L. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab. 2009;29:994-1002.
Babu PVA, Si H, Fu Z, Zhen W, Liu D. Genistein Prevents Hyperglycemia-Induced Monocyte Adhesion to Human Aortic Endothelial Cells through Preservation of the cAMP Signaling Pathway and Ameliorates Vascular Inflammation in Obese Diabetic Mice. J Nutr. 2012 Apr; 142(4): 724–730.
Ridker PM, Dane/lson E, Fonseca FA, Genest J, Gotto AM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2021 Medica Hospitalia : Journal of Clinical Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
